Results 211 to 220 of about 185,950 (370)
ABSTRACT Background In humans, deficiency of a disintegrin‐like and metalloprotease with thrombospondin type 1 motifs, number 13 (ADAMTS13), a von Willebrand factor (vWF) cleaving protease, is an underlying mechanism for thrombosis. The role of ADAMTS13 in canine thromboembolic disease is largely unknown.
Ashley R. Wilkinson +2 more
wiley +1 more source
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma) [PDF]
A Scheja +6 more
openalex +1 more source
ABSTRACT Objective To report homologous cryoprecipitate transfusions in dogs with hemostatic disorders, hemorrhage, or risk of hemorrhage, and to report adverse reactions associated with these cryoprecipitate transfusions. Design Retrospective case series (July 2009 to July 2023). Setting University teaching hospital.
W. Y. Eunice Lam +3 more
wiley +1 more source
Sexuality and bleeding in von Willebrand disease. [PDF]
van Kwawegen CB +16 more
europepmc +1 more source
von Willebrand disease phenotype and von Willebrand factor marker genotype in Doberman Pinschers [PDF]
Marjory B. Brooks +3 more
openalex +1 more source
An experimental comparison and user evaluation of three different dried plasma products
Abstract Background and Objectives Access to blood components in pre‐hospital bleeding resuscitation is challenging. Dried plasma is a logistically superior alternative, and new products are emerging. Therefore, we aimed to evaluate laboratory and practical differences in three differently produced dried plasma products.
Kristina Ehn +5 more
wiley +1 more source
How I treat patients with von Willebrand disease [PDF]
Pier Mannuccio Mannucci
openalex +1 more source
Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science
Soundarya N Selvam, P. James
semanticscholar +1 more source

